BioAtla, Inc. (BCAB) Misses Q2 EPS by 6c

BioAtla, Inc. (NASDAQ: BCAB) reported Q2 EPS of ($0.32), $0.06 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
• TEN Holdings files for 5 million share offering at $1.25 per share